Skip to main content

BIOMERICA INC

corporate_fare Company Profile

BIOMERICA INC

BMRA·NASDAQ·Life Sciences·CIK 0000073290

BIOMERICA INC is a global biomedical technology company that develops, patents, manufactures, and markets advanced diagnostic and therapeutic products. The company's diagnostic test kits analyze blood, urine, nasal, or fecal material from patients to diagnose various diseases, food intolerances, and other medical complications. These kits also measure or detect the presence and levels of specific bacteria, hormones, antibodies, antigens, and other substances that may exist in the human body in extremely small concentrations. BIOMERICA INC's medical diagnostic products are sold worldwide, primarily to clinical laboratories and point-of-care settings. Most products carry the Conformite Europeenne ("CE") mark and/or are registered with regulatory agencies in various countries for diagnostic use. Several products are also cleared by the U.S. Food and Drug Administration ("FDA") for sale in the United States. The company focuses on developing and marketing rapid diagnostic tests that are accurate, use easily obtained patient specimens, and are simple to perform without complex instrumentation. These include home use (over-the-counter) and professional use (physicians' office, clinics, etc.) rapid diagnostic test products. BIOMERICA INC's rapid point-of-care tests require limited to no instrumentation, deliver reliable results in minutes, and can be performed at home or in a physician's office. The company invests resources in the research and development of new products designed to diagnose and, in some cases, treat several major medical diseases.

BIOMERICA INC (NASDAQ:BMRA) is a publicly traded company in the Life Sciences sector. Wiseek monitors BMRA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Biomerica Secures $500K Capital Infusion by Selling Subsidiary Stake to CEO-Affiliated Buyers
  • Biomerica Secures $1.75M CDMO Contract, Offering New Revenue Stream
  • Biomerica's inFoods® IBS Secures $300 National Medicare Payment Rate, European Revenue Jumps 45%
  • BIOMERICA INC Reiterates Going Concern Warning Amidst Deepening Losses, Revenue Decline, and CFO Resignation
  • Biomerica Secures First Commercial Order for Hp Detect™ from Major European Lab Chain

Financial Snapshot

Fiscal year ended May 31, 2025
Revenue
$5.31M
Net Income
-$4.97M
Diluted EPS
-$2.16
Op. Cash Flow
-$3.84M
Gross Profit
$498K
Operating Income
-$5.14M
Cash & Equivalents
$2.4M
Debt / Equity
0.00×
Net Margin
-93.6%
Shares Outstanding
2.55M sh
Source: 10-K · filed 2025-09-26 · accession 0001493152-25-015785
Browse all tickers starting with B →
$2 -0.05% today
52-week range · as of 2026-06-04 $1.87 – $4.6
Market cap
$6.34M
Volume
12K (0.6× avg)
3-mo avg 20K
Live data · 2026-06-14 05:14 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BMRA - Latest Insights

BMRA
Jun 04, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $2.00 info
Change: -$0.145 (-7%) info
Market Cap: $6.335M info
BMRA
May 28, 2026, 8:19 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.65
Real-time Price: $2.00 info
Change: -$0.650 (-25%) info
Market Cap: $6.335M info
BMRA
Apr 13, 2026, 6:57 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.08
Real-time Price: $2.00 info
Change: -$0.080 (-4%) info
Market Cap: $6.335M info
BMRA
Apr 13, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.08
Real-time Price: $2.00 info
Change: -$0.080 (-4%) info
Market Cap: $6.335M info
BMRA
Mar 18, 2026, 8:19 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.26
Real-time Price: $2.00 info
Change: -$0.260 (-12%) info
Market Cap: $6.335M info
BMRA
Mar 05, 2026, 8:20 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.08
Real-time Price: $2.00 info
Change: -$0.080 (-4%) info
Market Cap: $6.335M info
BMRA
Jan 14, 2026, 5:15 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.70
Real-time Price: $2.00 info
Change: -$0.695 (-26%) info
Market Cap: $6.335M info